Aperam (OTCMKTS:APEMY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday.

According to Zacks, “Aperam S.A. is a manufacturer and marketer of stainless steel primarily in South America and Europe. The company produce grain oriented and non-grain oriented electrical steels and nickel alloys. Aperam S.A. is headquartered in Luxembourg. “

How to Become a New Pot Stock Millionaire

Separately, ValuEngine upgraded Aperam from a “hold” rating to a “buy” rating in a report on Wednesday, January 10th.

Aperam (OTCMKTS APEMY) opened at $48.76 on Tuesday. Aperam has a twelve month low of $43.50 and a twelve month high of $59.52. The firm has a market capitalization of $4,168.80, a P/E ratio of 12.16 and a beta of 2.20.

Aperam (OTCMKTS:APEMY) last posted its earnings results on Tuesday, January 30th. The company reported $1.29 earnings per share for the quarter. Aperam had a return on equity of 11.99% and a net margin of 7.15%. The firm had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.19 billion. analysts expect that Aperam will post 4.36 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This piece of content was posted by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2018/03/14/aperam-apemy-upgraded-to-hold-by-zacks-investment-research.html.

Aperam Company Profile

Aperam produces and sells stainless and specialty steel products worldwide. It operates through three segments: Stainless & Electrical Steel, Services & Solutions, and Alloys & Specialties. The company offers steel products and electrical steels, including grain oriented, non-grain oriented, and non-grain oriented semi-processed steel products.

Get a free copy of the Zacks research report on Aperam (APEMY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Aperam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aperam and related companies with MarketBeat.com's FREE daily email newsletter.